Medy-Tox Inc (086900) — Cash Flow Reinvestment Rate
Medy-Tox Inc (086900) has a Cash Flow Reinvestment Rate of 0.35x as of September 2025, reinvesting ₩6.73 Billion (capex ₩6.46 Billion plus investments ₩-268.49 Million) from operating cash flow of ₩19.03 Billion. Explore Medy-Tox Inc (086900) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Medy-Tox Inc Cash Flow Reinvestment Rate (2013–2024)
Historical reinvestment intensity for Medy-Tox Inc across 12 annual periods. Also explore balance sheet size of Medy-Tox Inc for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Medy-Tox Inc (2013–2024)
Year-by-year capital reinvestment analysis for Medy-Tox Inc. For live market cap and broader valuation context, see 086900 company net worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.53x | ₩19.37 Billion | ₩36.89 Billion | ₩18.72 Billion | ▼ -86.0% |
| 2023 | 3.75x | ₩50.72 Billion | ₩13.52 Billion | ₩37.47 Billion | ▲ +392.4% |
| 2022 | 0.76x | ₩19.96 Billion | ₩26.20 Billion | ₩9.90 Billion | ▼ -48.1% |
| 2021 | 1.47x | ₩29.32 Billion | ₩19.97 Billion | ₩17.51 Billion | ▼ -17.9% |
| 2020 | 1.79x | ₩49.95 Billion | ₩27.93 Billion | ₩41.14 Billion | ▲ +142.4% |
| 2019 | 0.74x | ₩24.87 Billion | ₩33.70 Billion | ₩21.02 Billion | ▲ +209.4% |
| 2018 | 0.24x | ₩13.13 Billion | ₩55.07 Billion | ₩8.50 Billion | ▼ -66.2% |
| 2017 | 0.70x | ₩39.86 Billion | ₩56.55 Billion | ₩38.04 Billion | ▼ -78.2% |
| 2016 | 3.24x | ₩175.28 Billion | ₩54.10 Billion | ₩144.67 Billion | ▲ +20.7% |
| 2015 | 2.68x | ₩60.05 Billion | ₩22.37 Billion | ₩33.81 Billion | ▲ +253.0% |
| 2014 | 0.76x | ₩80.13 Billion | ₩105.38 Billion | ₩16.64 Billion | ▼ -23.8% |
| 2013 | 1.00x | ₩16.55 Billion | ₩16.60 Billion | ₩16.55 Billion | — |